RxDoctor Payments Data
★ My doctorsLook up a doctor →

Steven Harwin

Orthopaedic Surgery · New York, NYNPI 1962465542

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (59.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Every reported general payment came from a single manufacturer, Stryker. Reporting peaked in 2019 at $827,596 and has fallen 74.4% since, to $212,010 in 2025. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,350,023in general payments, 2019–2025

Across 135 payments — averaging $17,408 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2.4M

What the payments were for

  • Royalty or licence$1,401,30860%
  • Consulting fees$941,25040%
  • Travel & lodging$6,1290%
  • Food & beverage$1,3360%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker135$2,350,023

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,350,023 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Other orthopaedic surgery in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →